Cited by 1,063Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Open access

Vilar, Eduardo, Gruber, Stephen B.·2010·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2009.237PMC PMC3427139

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2009.237

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876

Show all 100 references

Sorted by citations

Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Mlecnik, B., Tosolini, M., Kirilovsky, A., Berger, A., Bindea, G., Meatchi, T., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Pagès, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5425 · Cited by 1,009
Classification and characterization of microsatellite instability across 18 cancer types
Hause, R. J., Pritchard, C. C., Shendure, J., & Salipante, S. J. (2016) · Nature Medicine · doi:10.1038/nm.4191 · Cited by 982
Targeting DNA damage response pathways in cancer
Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N., & Tarsounas, M. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00535-5 · Cited by 890
A molecular portrait of microsatellite instability across multiple cancers
Cortés‐Ciriano, I., Lee, S., Park, W., Kim, T., & Park, P. J. (2017) · Nature Communications · doi:10.1038/ncomms15180 · Cited by 669
Evolution of the cancer genome
Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 682
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Germano, G., Lamba, S., Rospo, G., Barault, L., Magrì, A., Maione, F., Russo, M., Crisafulli, G., Bartolini, A., Lerda, G., et al. (2017) · Nature · doi:10.1038/nature24673 · Cited by 638
DNA mismatch repair in cancer
Baretti, M., & Le, D. T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.004 · Cited by 574
Mismatch Repair Deficiency, Microsatellite Instability, and Survival
Smyth, E. C., Wotherspoon, A. C., Peckitt, C., de Castro, D. G., Wilson, S. H., Eltahir, Z., Fassan, M., Rugge, M., Valeri, N., Okines, A. F. C., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6762 · Cited by 533
Patient-derived xenograft models in cancer therapy: technologies and applications
Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01419-2 · Cited by 533
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 545
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Chan, E. M., Shibue, T., McFarland, J. M., Gaeta, B., Ghandi, M., Dumont, N., Gonzalez, A., McPartlan, J. S., Li, T., Zhang, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1102-x · Cited by 458
Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer
Kawakami, H., Zaanan, A., & Sinicrope, F. A. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0348-2 · Cited by 429
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani, C., Miricescu, D., Stanescu-Spinu, I.-I., Nica, R. I., Greabu, M., Totan, A. R., & Jinga, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910260 · Cited by 402
Personalized Medicine: Progress and Promise
Chan, I. S., & Ginsburg, G. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101446 · Cited by 409
Hypermutation in human cancer genomes: footprints and mechanisms
Roberts, S. A., & Gordenin, D. A. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3816 · Cited by 403
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Şahin, İ. H., Akce, M., Alese, O. B., Shaib, W. L., Lesinski, G. B., El‐Rayes, B. F., & Wu, C. S.-Y. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0599-y · Cited by 404
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Haradhvala, N. J., Polak, P. P., Stojanov, P., Covington, K. R., Shinbrot, E., Hess, J. M., Rheinbay, E., Kim, J., Maruvka, Y. E., Braunstein, L. Z., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.050 · Cited by 395
Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
Li, J., Wu, C., Hu, H., Qin, G., Wu, X., Bai, F., Zhang, J., Cai, Y., Huang, Y. J., Wang, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.011 · Cited by 388
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition
Roepman, P., Schlicker, A., Tabernero, J. M., Majewski, I. J., Tian, S., Moreno, V. R., Snel, M. H. J., Chresta, C. M., Rosenberg, R., Nitsche, U., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28387 · Cited by 355
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G. L. M., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.005 · Cited by 352
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
Taı̈eb, J., Svrcek, M., Cohen, R., Basile, D., Tougeron, D., & Phelip, J. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.07.020 · Cited by 353
New concepts for an old problem: the diagnosis of endometrial hyperplasia
Sanderson, P. A., Critchley, H. O. D., Williams, A. R. W., Arends, M. J., & Saunders, P. T. K. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw042 · Cited by 323
Biomarker-guided therapy for colorectal cancer: strength in complexity
Sveen, A., Kopetz, S., & Lothe, R. A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0241-1 · Cited by 320
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
van Gool, I. C., Eggink, F. A., Freeman-Mills, L., Stelloo, E., Marchi, E., de Bruyn, M., Palles, C., Nout, R. A., de Kroon, C. D., Osse, E. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0057 · Cited by 323
The evolving role of microsatellite instability in colorectal cancer: A review
Gelsomino, F., Barbolini, M., Spallanzani, A., Pugliese, G., & Cascinu, S. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.005 · Cited by 318
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
Hu, H., Kang, L., Zhang, J., Wu, Z., Wang, H., Huang, M., Lan, P., Wu, X., Wang, C., Cao, W., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00348-4 · Cited by 314
Colorectal cancer carcinogenesis: a review of mechanisms
Tariq, K., Tariq, K., Ghias, K., & Ghias, K. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2015.0103 · Cited by 332
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
Ciardiello, D., Vitiello, P. P., Cardone, C., Martini, G., Troiani, T., Martinelli, E., & Ciardiello, F. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.04.003 · Cited by 310
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y., & Shitara, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00492-2 · Cited by 307
Microsatellite instability in colorectal cancer
Iacopetta, B. J., Grieu, F., & Amanuel, B. (2010) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2010.01335.x · Cited by 296
Overtreatment of Young Adults With Colon Cancer
Kneuertz, P. J., Chang, G. J., Hu, C., Rodrı́guez-Bigas, M. A., Eng, C., Vilar, E., Skibber, J. M., Feig, B. W., Cormier, J. N., & You, Y. N. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.3572 · Cited by 289
Self-citation
Immunotherapy, Inflammation and Colorectal Cancer
Lichtenstern, C. R., Ngu, R. K., Shalapour, S., & Karin, M. (2020) · Cells · doi:10.3390/cells9030618 · Cited by 296
Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replicationPreprint
Shinbrot, E., Henninger, E. E., Weinhold, N., Covington, K. R., Goksenin, A. Y., Schultz, N. D., Chao, H., Doddapaneni, H., Muzny, D. M., Gibbs, R. A., et al. (2014) · Genome Research · doi:10.1101/gr.174789.114 · Cited by 277
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer
Cao, R., Yang, F., Ma, S.-C., Liu, L., Zhao, Y. S., Li, Y., Wu, D., Wang, T., Lu, W., Cai, W.-J., et al. (2020) · Theranostics · doi:10.7150/thno.49864 · Cited by 270
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Duan, X., Chan, C., Han, W., Guo, N., Weichselbaum, R. R., & Lin, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09221-x · Cited by 256
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Ahmad, R., Singh, J. K., Wunnava, A., Al-Obeed, O. A., Abdulla, M., & Srivastava, S. K. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4847 · Cited by 265
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Pitroda, S. P., Khodarev, N. N., Huang, L., Uppal, A., Wightman, S. C., Ganai, S., Joseph, N. E., Pitt, J. J., Brown, M., Forde, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04278-6 · Cited by 253
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 266
Microsatellite instability: an update
Yamamoto, H., & Imai, K. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1474-0 · Cited by 247
Disease Detection and Management via Single Nanopore-Based Sensors
Reiner, J. E., Balijepalli, A. K., Robertson, J. W. F., Campbell, J. P., Suehle, J., & Kasianowicz, J. J. (2012) · Chemical Reviews · doi:10.1021/cr300381m · Cited by 247
Genomic Instability in Cancer: Teetering on the Limit of Tolerance
Andor, N., Maley, C. C., & Ji, H. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1553 · Cited by 246
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
Panou, V., Gadiraju, M., Wolin, A. R., Weipert, C. M., Skarda, E., Husain, A. N., Patel, J. D., Rose, B., Zhang, S. R., Weatherly, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.5204 · Cited by 228
Microsatellite instability in colorectal cancer.
de’Angelis, G. L., Bottarelli, L., Azzoni, C., de’Angelis, N., Leandro, G., Mario, F. D., Gaiani, F., & Negri, F. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i9-s.7960 · Cited by 233
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
Lizardo, D. Y., Kuang, C., Hao, S., Yu, J., Huang, Y., & Zhang, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188447 · Cited by 216
Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
Zeng, Y., & Jin, R. U. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.004 · Cited by 221
Familial risk for lung cancer
Kanwal, M., Ding, X., & Cao, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.5518 · Cited by 220
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Schell, M. J., Yang, M., Teer, J. K., Lo, F. Y., Madan, A., Coppola, D., Monteiro, A. N. A., Nebozhyn, M. V., Yue, B., Loboda, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11743 · Cited by 207
The detection and implication of genome instability in cancer
Pikor, L. A., Thu, K. L., Vucic, E. A., & Lam, W. L. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9429-5 · Cited by 216
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine
Valle, L., Vilar, E., Tavtigian, S. V., & Stoffel, E. M. (2018) · The Journal of Pathology · doi:10.1002/path.5229 · Cited by 213
Self-citation
Colorectal Cancer Disparity in African Americans
Augustus, G. J., & Ellis, N. A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.023 · Cited by 186
Colorectal Cancers: An Update on Their Molecular Pathology
Inamura, K. (2018) · Cancers · doi:10.3390/cancers10010026 · Cited by 182
Inhibitors of the PD-1 Pathway in Tumor Therapy
LaFleur, M. W., Muroyama, Y., Drake, C. G., & Sharpe, A. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701044 · Cited by 180
Tumor Heterogeneity in Colorectal Cancer: What Do We Know So Far?
Sagaert, X., Vanstapel, A., & Verbeek, S. (2018) · Pathobiology · doi:10.1159/000486721 · Cited by 179
Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome
Raymond, V. M., Mukherjee, B., Wang, F., Huang, S.-C., Stoffel, E. M., Kastrinos, F., Syngal, S., Cooney, K. A., & Gruber, S. B. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1238 · Cited by 170
Self-citation
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
de Mestier, L., Cros, J. F., Neuzillet, C., Hentic, O., Egal, A., Müller, N., Bouché, O., Cadiot, G., Ruszniewski, P. B., Couvelard, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000475527 · Cited by 163
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma
Kannarkatt, J., Joseph, J. P., Kurniali, P. C., Al-Janadi, A., & Hrinczenko, B. W. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.017210 · Cited by 162
Microsatellite instability in colorectal cancer
Nojadeh, J. N., Sharif, S. B., & Sakhinia, E. (2018) · Europe PMC (PubMed Central) · doi:10.17179/excli2017-948 · Cited by 162
Genome-Wide Sex and Gender Differences in Cancer
Lopes‐Ramos, C. M., Quackenbush, J. F., & DeMeo, D. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.597788 · Cited by 168
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms
Chu, X., Li, X., Zhang, Y., Dang, G., Miao, Y., Xu, W., Wang, J., Zhang, Z., & Cheng, S. (2024) · Nature Cancer · doi:10.1038/s43018-024-00807-z · Cited by 183
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis
Smedt, L. D., Lemahieu, J., Palmans, S., Govaere, O., Tousseyn, T., Cutsem, E. V., Prenen, H., Tejpar, S., Spaepen, M., Matthijs, G., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.213 · Cited by 161
A genomic view of short tandem repeats
Gymrek, M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.012 · Cited by 161
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Chheda, Z. S., Sharma, R. K., Jala, V. R., Luster, A. D., & Haribabu, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502376 · Cited by 159
The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
Takahashi, M., Cuatrecasas, M., Balaguer, F., Hur, K., Toiyama, Y., Castells, A., Boland, C. R., & Goel, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046684 · Cited by 153
MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers
Vilar, E., Bartnik, C. M., Stenzel, S. L., Raskin, L., Ahn, J., Moreno, V. R., Mukherjee, B., Iniesta, M. D., Morgan, M. A., Rennert, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1120 · Cited by 148
Self-citation
Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors
Cicek, M. S., Lindor, N. M., Gallinger, S., Bapat, B. V., Hopper, J. L., Jenkins, M. A., Young, J. P., Buchanan, D. D., Walsh, M. D., Marchand, L. L., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.004 · Cited by 148
Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer
Hasan, S., Renz, P. B., Wegner, R. E., Finley, G. G., Raj, M. S., Monga, D. K., McCormick, J., & Kirichenko, A. V. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000003051 · Cited by 147
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
Morganti, S., Tarantino, P., Ferraro, E., D’Amico, P., Viale, G., Trapani, D., Duso, B. A., & Curigliano, G. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.11.008 · Cited by 151
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
Papeo, G., Posteri, H., Borghi, D., Busel, A. A., Caprera, F., Casale, E., Ciomei, M., Cirla, A., Corti, E., D’Anello, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00680 · Cited by 147
Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review
Davri, A. S., Birbas, E., Kanavos, T., Ntritsos, G., Γιαννακέας, Ν., Tzallas, A. T., & Batistatou, A. K. (2022) · Diagnostics · doi:10.3390/diagnostics12040837 · Cited by 144
Intestinal bacteria and colorectal cancer: etiology and treatment
Dougherty, M. W., & Jobin, C. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185028 · Cited by 145
Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer
Luo, X.-J., Zhao, Q., Liu, J. S., Zheng, J., Qiu, M., Ju, H., & Xu, R. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.017 · Cited by 140
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 138
MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations
Huang, M. N., McPherson, J. R., Cutcutache, I., Teh, B. T., Tan, P. B. O., & Rozen, S. (2015) · Scientific Reports · doi:10.1038/srep13321 · Cited by 140
Mutations of epigenetic regulatory genes are common in thymic carcinomas
Wang, Y., Thomas, A., Lau, C. C., Rajan, A., Zhu, Y. J., Killian, J. K., Petrini, I., Pham, T. C., Morrow, B., Zhong, X., et al. (2014) · Scientific Reports · doi:10.1038/srep07336 · Cited by 135
Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis
Díaz-Padilla, I., Romero-Laorden, N., Amir, E., Matías‐Guiu, X., Vilar, E., Muggia, F. M., & García-Donás, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.002 · Cited by 135
Self-citation
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
Lee, D., Han, S., Bae, J. M., Jang, H. S., Han, H., Kim, H., Bang, D., Jeong, S., Park, K. J., Kang, G. H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1105 · Cited by 137
Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
Underwood, P. W., Ruff, S. M., & Pawlik, T. M. (2024) · Cells · doi:10.3390/cells13030245 · Cited by 130
Serrated pathway in colorectal carcinogenesis
Yamane, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2634 · Cited by 130
The Clinical Impact of the Genomic Landscape of Mismatch Repair–Deficient Cancers
Germano, G., Amirouchene-Angelozzi, N., Rospo, G., & Bardelli, A. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0150 · Cited by 130
Analysis of somatic microsatellite indels identifies driver events in human tumors
Maruvka, Y. E., Mouw, K. W., Karlić, R., Parasuraman, P., Kamburov, A., Polak, P. P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 126
Precision medicine becomes reality—tumor type‐agnostic therapy
Li, Y., & Zhang, W. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0274-3 · Cited by 121
DNA Damage Response and Immune Defense
Nastasi, C., Mannarino, L., & D’Incalci, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207504 · Cited by 127
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
Hempelmann, J. A., Lockwood, C. M., Konnick, E. Q., Schweizer, M. T., Antonarakis, E. S., Lotan, T. L., Montgomery, B., Nelson, P. S., Klemfuss, N. M., Salipante, S. J., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0341-y · Cited by 117
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern
Prasanna, T., Karapetis, C. S., Roder, D. M., Tie, J., Padbury, R., Price, T. J., Wong, R., Shapiro, J. D., Nott, L. M., Lee, M., et al. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1487581 · Cited by 114
Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer
Kastrinos, F., Samadder, N. J., & Burt, R. W. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.11.029 · Cited by 113
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
Picco, G., Cattaneo, C. M., van Vliet, E. J., Crisafulli, G., Rospo, G., Consonni, S., Vieira, S. F., Sánchez-Rodríguez, I., Cancelliere, C., Banerjee, R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1508 · Cited by 112
Molecular Dissection of Microsatellite Instable Colorectal Cancer
Vilar, E., & Tabernero, J. M. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0471 · Cited by 112
Self-citation
DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics
de Rosa, N., Rodrı́guez-Bigas, M. A., Chang, G. J., Veerapong, J., Borràs, E., Krishnan, S., Bednarski, B. K., Messick, C. A., Skibber, J. M., Feig, B. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6826 · Cited by 109
Self-citation
Integrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
McGrail, D. J., Garnett, J., Yin, J., Dai, H., Shih, D. J. H., Lam, T., Li, Y., Sun, C., Li, Y., Schmandt, R. E., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.011 · Cited by 109
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Mulet-Margalef, N., Linares, J., Badia-Ramentol, J., Jimeno, M., Sanz, C., Mozo, J. L. M., & Calon, A. (2023) · Cancers · doi:10.3390/cancers15041022 · Cited by 112
Next-generation sequencing: recent applications to the analysis of colorectal cancer
Vecchio, F. D., Mastroiaco, V., Marco, A. D., Compagnoni, C., Capece, D., Zazzeroni, F., Capalbo, C., Alesse, E., & Tessitore, A. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1353-y · Cited by 110
Immune Activation in Mismatch Repair–Deficient Carcinogenesis: More Than Just Mutational Rate
Willis, J. A., Reyes-Uribe, L., Chang, K., Lipkin, S. M., & Vilar, E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0856 · Cited by 104
Self-citation
TSVdb: a web-tool for TCGA splicing variants analysis
Sun, W., Duan, T., Ye, P., Chen, K., Zhang, G., Lai, M., & Zhang, H. (2018) · BMC Genomics · doi:10.1186/s12864-018-4775-x · Cited by 103
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI
Deschoolmeester, V., Baay, M. F. D., Lardon, F., Pauwels, P., & Peeters, M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0068-5 · Cited by 99
Mutational profiling of colorectal cancers with microsatellite instability
Lin, E. I., Tseng, L., Gocke, C. D., Reil, S., Le, D. T., Azad, N. S., & Eshleman, J. R. (2015) · Oncotarget · doi:10.18632/oncotarget.5997 · Cited by 95
The Cancer Immunotherapy Biomarker Testing Landscape
Walk, E. E., Yohe, S. L., Beckman, A., Schade, A. E., Zutter, M. M., Pfeifer, J. D., & Berry, A. B. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0584-cp · Cited by 95

Authors: Vilar, E., & Gruber, S. B.
Affiliations: University of Michigan (US)
Corresponding author: Gruber, Stephen B.
ORCID: Vilar, Eduardo
Gruber, Stephen B.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2010-02-09
Volume: 7
Issue: 3
Pages: 153-162
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/nrclinonc.2009.237
PMC: PMC3427139
OpenAlex: W2050658928
Cited by: 1,063
References: 100
Citations by year: 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
FWCI: 4.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
MeSH terms: DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks